Clinical trial
Study of Gelonin Purging of Autologous Stem Cells for Transplantation
NCT00043810 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00043810 |
|---|---|
| Title | Study of Gelonin Purging of Autologous Stem Cells for Transplantation |
| Official title | Dose Finding Study of Gelonin Purging of Autologous Stem Cells for Transplantation of Patients With AML/MDS in First or Subsequent Remission |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myelogenous Leukemia, Myelodysplastic Syndrome |
| Intervention type | Drug, Procedure |
| Interventions | Gelonin, Busulfan, Fludarabine |
| Enrollment | 3 |
| Start date | Jul 1, 2002 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Aug 15, 2002 |
| Last update posted | Oct 31, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: